Tag: ANE Logistics

January 21, 2020, Beijing – Centurium Capital (“Centurium” or the “Firm”), a leading private equity firm in China, announced today that it has completed an investment of over US$ 300 million into ANE Logistics (“ANE” or the “Company”). ANE, the leading less-than-truckload (“LTL”) trucking logistics company in China, plans to use the financing to invest in technology and operations to further solidify its market leadership position.

ANE’s daily LTL shipments reached close to 40,000 tons and its total number of franchise depots was over 20,000 as of December 2019, covering 96% of towns and townships in China.  

With a growing and well-run network of depots and trunk-lines, ANE has been steadily improving its profitability through effective cost management and increased operational efficiency.

Yongjun Wang, Chairman of ANE, commented, “The trend towards concentration in China’s logistics industry is obvious. We see great opportunities over the next five years to expand our network, optimize operational efficiency and improve service quality. We will work hard to achieve the strategic goal of an average daily cargo volume of 100,000 tons and a market value of over RMB100 billion ($14 billion).”

Michael Chen, Partner of Centurium, commented, “ANE Logistics is a clear leader in China’s LTL logistics sector and a pioneer with an innovative, technology-driven franchise model providing quality solutions to its clients. We believe that our capital and support will assist the company in its goal to further consolidate the market and solidify its leadership position.”

Centurium’s investment philosophy is to identify investment opportunities in China’s rapidly expanding consumer, services, and healthcare sectors, with an investment strategy centered around the need to “Invest to Transform”. Moreover, the Firm brings a hands-on and operations-centric approach to improve operational efficiency and solve structural deficiencies. Investments made by the Firm include, among other, Luckin Coffee (NASDAQ: LK), China Biologic Products (NASDAQ: CBPO), LOHO and UIB.